Uploads Contact
/
Login Upload

  • Search Results for 'Rituximab Patients'

Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
conchita-marotz
Indolent Non-Hodgkin L
Indolent Non-Hodgkin L
danika-pritchard
Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI)
Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI)
ellena-manuel
Update on Follicular Lymphoma:
Update on Follicular Lymphoma:
tatiana-dople
Update on Follicular Lymphoma:
Update on Follicular Lymphoma:
alexa-scheidler
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive
mitsue-stanley
Please note, these are the actual video-recorded proceeding
Please note, these are the actual video-recorded proceeding
luanne-stotts
Integration of Novel Therapies in WM and CLL : When and How
Integration of Novel Therapies in WM and CLL : When and How
giovanna-bartolotta
Chronic lymphocytic leukemia,
Chronic lymphocytic leukemia,
natalia-silvester
A Closer Look at Pemphigus Vulgaris: Clinical Challenges and
A Closer Look at Pemphigus Vulgaris: Clinical Challenges and
celsa-spraggs
Mantelcell
Mantelcell
tawny-fly
Overall Survival Benefit of
Overall Survival Benefit of
tatyana-admore
Updates in Lymphoma From Recent Congresses
Updates in Lymphoma From Recent Congresses
lindy-dunigan
HIV and Non Hodgkin Lymphoma
HIV and Non Hodgkin Lymphoma
karlyn-bohler
RituximabinIndolentLymphomasTarekSousouandJonathanFriedberg
RituximabinIndolentLymphomasTarekSousouandJonathanFriedberg
kittie-lecroy
Drug Treatment of Hematopoietic Malignancy
Drug Treatment of Hematopoietic Malignancy
mitsue-stanley
Recruitment of cancer patients by LCRN
Recruitment of cancer patients by LCRN
karlyn-bohler
Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less
Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less
debby-jeon
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3
kittie-lecroy
Applying Biosimilars in Hematologic Cancers
Applying Biosimilars in Hematologic Cancers
conchita-marotz
New Perspectives in Treatment Strategies for Follicular Lymphoma
New Perspectives in Treatment Strategies for Follicular Lymphoma
olivia-moreira
Indolent Lymphomas Dr. Melissa Toupin
Indolent Lymphomas Dr. Melissa Toupin
liane-varnes
Understanding Biologics Biologics and Biosimilars
Understanding Biologics Biologics and Biosimilars
calandra-battersby
Can we safely discharge TIA patients?
Can we safely discharge TIA patients?
min-jolicoeur